Offer - Urjas Oil for just ₹ 1 X
Ropark 0.25 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Parkinson's Disease, Restless Legs Syndrome. Ropark 0.25 Mg Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Ropark 0.25 Mg Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Ropark 0.25 Mg Tablet include Sleepiness, Weakness, Influenza like symptoms. Some other side effects of Ropark 0.25 Mg Tablet have been listed ahead. Such side effects of Ropark 0.25 Mg Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Ropark 0.25 Mg Tablet's effect during pregnancy is Moderate and Severe while nursing. Further, the section on Ropark 0.25 Mg Tablet related warnings talks about Ropark 0.25 Mg Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Low Blood Pressure (Hypotension), Psychosis must refrain from the use of Ropark 0.25 Mg Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Ropark 0.25 Mg Tablet are listed in the contraindications section below.
Drug reaction of Ropark 0.25 Mg Tablet with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Ropark 0.25 Mg Tablet is considered not safe while driving, and is not addictive.
Ropark 0.25 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Ropark 0.25 Mg Tablet safe for pregnant women?
Ropark can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Ropark right away. Take your doctor's advice before taking it again.
Is the use of Ropark 0.25 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Ropark. So it is adviced to consult the doctor before using it.
What is the effect of Ropark 0.25 Mg Tablet on the Kidneys?
Ropark rarely affects the kidneys.
What is the effect of Ropark 0.25 Mg Tablet on the Liver?
Very few cases of side effects of Ropark on the liver have been reported.
What is the effect of Ropark 0.25 Mg Tablet on the Heart?
Ropark may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Ropark 0.25 Mg Tablet unless your doctor advises you to do so -
Is this Ropark 0.25 Mg Tablet habit forming or addictive?
Ropark 0.25 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Ropark 0.25 Mg Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Ropark 0.25 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Ropark 0.25 Mg Tablet can help with mental disorders.
Interaction between Food and Ropark 0.25 Mg Tablet
When consumed with certain foods, Ropark 0.25 Mg Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Ropark 0.25 Mg Tablet
Consumption of alcohol and Ropark 0.25 Mg Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Requip (ropinirole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1114-1116